Skip to content
Certara Drug Interaction Solutions
  • About Us
    • What we do
    • How we work
    • Our team
    • History
    • Linked
  • Our Solutions
    • DIDB® – The Drug Interaction Database
    •   Human in vitro datasets
    •   Clinical datasets
    • Custom solutions
    • Testimonials
  • Licensing
    • Does my organization have a DIDB® license?
    • Licensing
    • Account policies
  • News
  • Support
  • Contact Us
  • Sign in
June 14, 2022 |  News

Data Curation and Entry in DIDB – May Summary

In May, we added 74 citations in DIDB, including 29 in vitro (with 15 articles published in May 2022) and 45 in vivo articles (with 32 articles published in May 2022).

One recently approved NDA was also added: Ganaxolone (ZTALMY)

You can check the citations that are recently published and entered in DIDB and all the NDAs/BLAs in DIDB.

As always, feel free to contact us if you have any questions or comments.

Post navigation

New features! Drug Characteristics now integrated in queries
Assessing the Effects of Food on Drugs in INDs and NDAs – Clinical Pharmacology Considerations
Follow us on Linked

Brochures

  • Why us?
  • Human in vitro drug metabolism
  • Human in vitro drug transporter
  • Clinical drug interaction
  • Clinical organ impairment
  • Clinical pharmacogenetics

News Categories

  • Events
  • New features
  • News
  • Posters
  • Publications

Recent News

  • DDI Marker Studies Knowledgebase – quarterly update
  • Data Curation and Entry in DIDB – March Summary
  • Data Curation and Entry in DIDB – Feb Summary
  • All 2024 NDAs and BLAs now fully curated into DIDB
  • Data Curation and Entry in DIDB – January Summary
  • Blog
  • Contact
  • Privacy
Copyright © 2025 Certara, USA. All Rights Reserved.